Takeda awards 22,570 RSUs to HR chief
Greenway Nicola Deidre Petal reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Greenway Nicola Deidre Petal reported acquisition or exercise transactions in this Form 4 filing.
Takeda Pharmaceutical reported that Chief Human Resources Officer Nicola Deidre Petal Greenway received an equity award of 22,570 American Depositary Shares in the form of restricted stock units (RSUs). The units were granted at no cash cost to her as compensation.
Each RSU represents a contingent right to one American Depositary Share and will vest in three equal annual installments beginning on July 1, 2027. After this award, Greenway directly holds 94,406 American Depositary Shares, highlighting a meaningful ongoing equity stake that ties her compensation to Takeda’s long-term performance.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | American Depositary Shares | 22,570 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.
Key Figures
Key Terms
restricted stock units (RSUs) financial
vest in three equal annual installments financial
FAQ
What insider transaction did Takeda (TAK) report for Nicola Greenway?
What are the vesting terms of Nicola Greenway’s RSUs at Takeda (TAK)?
What does the RSU award in Takeda (TAK) stock mean for Nicola Greenway?
Was Nicola Greenway’s Takeda (TAK) RSU grant an open-market purchase or compensation?
AI-generated analysis. How Rhea-AI works. Not financial advice.